1506 related articles for article (PubMed ID: 34055110)
1. Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(2):1-125. PubMed ID: 34055110
[TBL] [Abstract][Full Text] [Related]
2. Placental Growth Factor (PlGF)- Based Biomarker Testing to Help Diagnose Pre-eclampsia in People With Suspected Pre-eclampsia: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2023; 23(3):1-146. PubMed ID: 37284279
[TBL] [Abstract][Full Text] [Related]
3. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
[TBL] [Abstract][Full Text] [Related]
4. Internet-Delivered Cognitive Behavioural Therapy for Post-traumatic Stress Disorder or Acute Stress Disorder: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(9):1-120. PubMed ID: 34527087
[TBL] [Abstract][Full Text] [Related]
5. Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates.
Gokulakrishnan G; Kulkarni M; He S; Leeflang MM; Cabrera AG; Fernandes CJ; Pammi M
Cochrane Database Syst Rev; 2022 Dec; 12(12):CD013129. PubMed ID: 36478359
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(15):1-160. PubMed ID: 33240456
[TBL] [Abstract][Full Text] [Related]
7. Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(11):1-178. PubMed ID: 32194879
[TBL] [Abstract][Full Text] [Related]
8. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care.
Mant J; Doust J; Roalfe A; Barton P; Cowie MR; Glasziou P; Mant D; McManus RJ; Holder R; Deeks J; Fletcher K; Qume M; Sohanpal S; Sanders S; Hobbs FD
Health Technol Assess; 2009 Jul; 13(32):1-207, iii. PubMed ID: 19586584
[TBL] [Abstract][Full Text] [Related]
9. Proton Beam Therapy for Cancer in Children and Adults: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(1):1-142. PubMed ID: 34055109
[TBL] [Abstract][Full Text] [Related]
10. Pre-surgical Nasal Decolonization of
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2022; 22(4):1-165. PubMed ID: 36160757
[TBL] [Abstract][Full Text] [Related]
11. Bariatric Surgery for Adults With Class I Obesity and Difficult-to-Manage Type 2 Diabetes: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2023; 23(8):1-151. PubMed ID: 38130940
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal Drug Delivery Systems for Cancer Pain: A Health Technology Assessment.
Ontario Health
Ont Health Technol Assess Ser; 2024; 24(2):1-162. PubMed ID: 38344326
[TBL] [Abstract][Full Text] [Related]
13.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(14):1-186. PubMed ID: 34484488
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Valve Stenosis at Low Surgical Risk: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(14):1-148. PubMed ID: 33240455
[TBL] [Abstract][Full Text] [Related]
15. Molecular Testing for Thyroid Nodules of Indeterminate Cytology: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2022; 22(2):1-111. PubMed ID: 35591972
[TBL] [Abstract][Full Text] [Related]
16. Structured Education and Neuromuscular Exercise Program for Hip and/or Knee Osteoarthritis: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2018; 18(8):1-110. PubMed ID: 30443280
[TBL] [Abstract][Full Text] [Related]
17. Potential impact of N-terminal pro-BNP testing on the emergency department evaluation of acute dyspnea.
Murray H; Cload B; Collier CP; Sivilotti ML
CJEM; 2006 Jul; 8(4):251-8. PubMed ID: 17324304
[TBL] [Abstract][Full Text] [Related]
18. Gene Expression Profiling Tests for Early-Stage Invasive Breast Cancer: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(10):1-234. PubMed ID: 32284770
[TBL] [Abstract][Full Text] [Related]
19. Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2023; 23(4):1-398. PubMed ID: 37637488
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
